Oridonin Inhibits SARS‐CoV‐2 by Targeting Its 3C‐Like Protease

Mostrar otras versiones (1)

The current COVID‐19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is an enormous threat to public health. The SARS‐CoV‐2 3C‐like protease (3CLpro), which is critical for viral replication and transcription, has been recognized as an ideal drug target. Herein, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Baisen, Peng, Weiyu, Du, Shan, Chen, Bingyi, Feng, Yajuan, Hu, Xinfeng, Lai, Qi, Liu, Shujie, Zhou, Zhong-Wei, Fang, Pengfei, Wu, Yan, Gao, Feng, Zhou, Huihao, Sun, Litao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111243/
https://www.ncbi.nlm.nih.gov/pubmed/35600064
http://dx.doi.org/10.1002/smsc.202100124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111243/
https://www.ncbi.nlm.nih.gov/pubmed/35600064
http://dx.doi.org/10.1002/smsc.202100124

Ejemplares similares